Single Dose of PF-06835919 Escalation Study in Healthy Adult Subjects

Status:
Completed

Trial end date:
2017-01-01

Target enrollment:

Participant gender:

The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of a single dose of PF-06835919 in healthy adult subjects.

Phase 1

Pfizer